Safety and efficacy of fixed dose combination of indapamide SR/Amlodipine in single- pill versus free dual therapy at the same dose over 12 – week of treatment, with conditional titration based on the blood pressure control, in patients with mild to moder
DATE – 2011 -2013
Name of the specialist – Hayrapetyan G.G.
Role – Principal Investigator
– International multicenter open placebo – controlled research (protocol of the research CL3 – 055)
Jointly participating Organization – Servier Laboratories (France) (Gagik Velijanyan, www.servier.com/)
Result – the research is not finished yet
Publications – none yet